Clinical Trial Update: Doripenem in the Treatment of Ventilator-Associated Pneumonia [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating doripenem for ventilator-associated pneumonia has completed. The sponsor is Johnson & Johnson Pharmaceutical Research & Development…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Doribax (doripenem)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Pneumonia, Ventilators, Mechanical | Phase 3 | Status: COMPLETED